DCF Advisers’s Evotec EVO Stock Holding History

DCF Advisers’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.66M	Sell	1,065,274 -133,719	-11%	-$431K	0.71%	35
2025 Q4	$3.69M	Hold	1,198,993	–	–	0.99%	30
2025 Q3	$4.35M	Buy	1,198,993 +84,500	+8%	+$321K	1.4%	23
2025 Q2	$4.68M	Buy	1,114,493 +362,914	+48%	+$1.42M	2.17%	15
2025 Q1	$2.51M	Buy	751,579 +521,708	+227%	+$2.13M	1.2%	29
2024 Q4	$956K	Buy	229,871 +12,816	+6%	+$53.8K	0.46%	54
2024 Q3	$792K	Buy	217,055 +102,102	+89%	+$405K	0.32%	60
2024 Q2	$552K	Buy	114,953 +67,156	+141%	+$377K	0.28%	63
2024 Q1	$374K	Hold	47,797	–	–	0.18%	69
2023 Q4	$561K	Sell	47,797 -1,250	-3%	-$12.3K	0.3%	55
2023 Q3	$484K	Buy	49,047 +6,309	+15%	+$74.1K	0.26%	64
2023 Q2	$483K	Buy	42,738 +30,350	+245%	+$324K	0.26%	62
2023 Q1	$129K	Buy	+12,388	New	+$118K	0.08%	64

Other funds holding EVO

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

DCF Advisers's EVO Position: Q1 2026 in Review

DCF Advisers reduced its Evotec (EVO) stake by 11% in Q1 2026, selling an estimated $431K and leaving 1,065,274 shares worth $2.66M. The position accounts for 0.71% of the portfolio, ranked #35.

DCF Advisers first reported a position in EVO in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.68M in Q2 2025. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

DCF Advisers held 1,065,274 shares of Evotec worth $2.66M as of Q1 2026.
DCF Advisers sold 133,719 Evotec shares in Q1 2026, an estimated $431K.
Evotec made up 0.71% of DCF Advisers's portfolio in Q1 2026, its #35 holding.
DCF Advisers first reported a position in Evotec in Q1 2023 and has held it in 13 quarters since.
DCF Advisers's Evotec position peaked at $4.68M in Q2 2025.
46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.